The role of necroptosis in cancer biology and therapy
Y Gong, Z Fan, G Luo, C Yang, Q Huang, K Fan… - Molecular cancer, 2019 - Springer
Apoptosis resistance is to a large extent a major obstacle leading to chemotherapy failure
during cancer treatment. Bypassing the apoptotic pathway to induce cancer cell death is …
during cancer treatment. Bypassing the apoptotic pathway to induce cancer cell death is …
[HTML][HTML] Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer
J Swierczynski, A Hebanowska… - World journal of …, 2014 - ncbi.nlm.nih.gov
There is growing evidence that metabolic alterations play an important role in cancer
development and progression. The metabolism of cancer cells is reprogrammed in order to …
development and progression. The metabolism of cancer cells is reprogrammed in order to …
NUPR1 is a critical repressor of ferroptosis
Ferroptosis is a type of iron-dependent regulated cell death, representing an emerging
disease-modulatory mechanism. Transcription factors play multiple roles in ferroptosis …
disease-modulatory mechanism. Transcription factors play multiple roles in ferroptosis …
Targeting intrinsically disordered proteins involved in cancer
Intrinsically disordered proteins (IDPs) do not have a well-defined structure under
physiological conditions, but they have key roles in cell signaling and regulation, and they …
physiological conditions, but they have key roles in cell signaling and regulation, and they …
NUPR1 inhibitor ZZW-115 induces ferroptosis in a mitochondria-dependent manner
C Huang, P Santofimia-Castaño, X Liu, Y Xia… - Cell death …, 2021 - nature.com
Ferroptosis is an iron-dependent cell death characterized by the accumulation of
hydroperoxided phospholipids. Here, we report that the NUPR1 inhibitor ZZW-115 induces …
hydroperoxided phospholipids. Here, we report that the NUPR1 inhibitor ZZW-115 induces …
HSF1 as a cancer biomarker and therapeutic target
RL Carpenter, Y Gökmen-Polar - Current cancer drug targets, 2019 - ingentaconnect.com
Heat shock factor 1 (HSF1) was discovered in 1984 as the master regulator of the heat
shock response. In this classical role, HSF1 is activated following cellular stresses such as …
shock response. In this classical role, HSF1 is activated following cellular stresses such as …
Pancreatic cancer: molecular characterization, clonal evolution and cancer stem cells
E Pelosi, G Castelli, U Testa - Biomedicines, 2017 - mdpi.com
Pancreatic Ductal Adenocarcinoma (PDAC) is the fourth most common cause of cancer-
related death and is the most lethal of common malignancies with a five-year survival rate …
related death and is the most lethal of common malignancies with a five-year survival rate …
Loss of ATM accelerates pancreatic cancer formation and epithelial–mesenchymal transition
Pancreatic ductal adenocarcinoma (PDAC) is associated with accumulation of particular
oncogenic mutations and recent genetic sequencing studies have identified ataxia …
oncogenic mutations and recent genetic sequencing studies have identified ataxia …
Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis
P Santofimia-Castaño, Y Xia, W Lan… - The Journal of …, 2019 - Am Soc Clin Investig
Intrinsically disordered proteins (IDPs) are emerging as attractive drug targets by virtue of
their prevalence in various diseases including cancer. Drug development targeting IDPs is …
their prevalence in various diseases including cancer. Drug development targeting IDPs is …
Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with marked
chemoresistance and a 5-year survival rate of 7%. The integrated stress response (ISR) is a …
chemoresistance and a 5-year survival rate of 7%. The integrated stress response (ISR) is a …